News About: Pharm. Industry
Pfizer loaded with three creative and improved pharmaceutical products
It is having the similar effect with existing products as well as better merits.
They are the similarities of pipelines that Pfizer added in the Korean market, recently.
Products related are an antidepressant drug ‘...
Comparison of 8 Japanese pharmaceutical companies on the third quarter of the year
It was shown that among Japanese pharmaceutical companies branched in Korea had different sales records on the third quarter of the year.
They seem ‘pretty good’ overall in the amount of prescriptions; although 5 com...
Despite the decline of its prescription, Baraclude still stays in the top… Viread is chasing aggresively
The hepatitis B drug, ‘Viread’ emerging as a star from a dark horse, has been accelerated to catch ‘Baraclude’.
According to the Medipana News’s accumulated results created based on the UBIST’s
data of collective pre...
RB Korea became an official member of KRPIA recently
RB Korea’s effort to establish image as a pharmaceutical company is actively ongoing.
According to a person concerned on the 21st, RB Korea recently finished to register as a official member of Korean Research-based ...
Domestic pharmaceutical companies’ changes in means of overseas expansion to reduce risks
There have been changes in means of domestic pharmaceutical companies’ overseas expansion in Korea. They used to be direct infiltration strategies in the past, but now they are moving towards indirect infiltration str...
Domestic and multinational pharmaceutical companies are focusing on OTC drugs
In the pharmaceutical industry, it seems that investments on Over The Counter (OTC) medicines will get more popular. It was observed that companies are getting ready to concentrate on the OTC market in various ways.
...
Are non-stoppable multinational pharmaceutical companies so far stuck in difficult situations?
Multinational pharmaceutical companies are surrounded by serious issues. They have been non-stoppable in the pharmaceutical industry, but now they are getting pressured by different organizations.
First and foremost,...
Desperation of multinational pharmaceutical companies on KRW 1 bid products
Multinational pharmaceutical companies are competing against domestic pharmaceutical companies in Korea to make contracts for KRW 1 bid products.
According to the industry concerned on the 17th, many companies, even ...
‘Promotion strategies using academic approaches’… Which companies showed up at the diabetes conference?
It is getting obvious on multinational pharmaceutical companies’ business strategies leaning towards academic aspects.
Korean Diabetes Association held an autumn academic conference at the Ilsan Kintex, scheduled for...
After the end of the conflict between the pharmaceutical distribution companies and GSK, multinational pharmaceutical companies has suddenly changed their attitudes
After the end of the conflict between GlaxoSmithKline (GSK) and the pharmaceutical distribution companies, multinational pharmaceutical companies are starting to change their attitudes.
Changes in their existing poli...
